StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

Equities research analysts at StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a research report issued on Monday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Stock Up 2.2 %

CUTR stock opened at $0.46 on Monday. The firm has a market capitalization of $9.29 million, a PE ratio of -0.07 and a beta of 1.31. Cutera has a twelve month low of $0.28 and a twelve month high of $4.81. The stock’s 50 day moving average is $0.40 and its 200-day moving average is $0.76.

Institutional Trading of Cutera

A hedge fund recently raised its stake in Cutera stock. Bank of Montreal Can boosted its holdings in Cutera, Inc. (NASDAQ:CUTR) by 14.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 282,704 shares of the medical device company’s stock after buying an additional 35,248 shares during the period. Bank of Montreal Can owned approximately 1.41% of Cutera worth $455,000 as of its most recent filing with the Securities and Exchange Commission. 90.70% of the stock is owned by hedge funds and other institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.